Delivery Order SPE2DB22D3011-SPE2DB25FQ2XV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,374.96 to AmerisourceBergen Drug Corp on May 12, 2025, for PROQUAD vials, with a completion date of June 3, 2025. This non-set-aside, firm fixed-price delivery order will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and critical federal vendor specializing in medical procurement for military and veteran healthcare systems, with...
- The Defense Logistics Agency awarded a $6,405.01 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ProQuad vials with an ultimate completion date of August 12, 2025. This non-set-aside contract was competitively awarded and reflects the agency's ongoing pharmaceutical procurement through its Medical Supply Chain. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary distribution...
- The Defense Logistics Agency awarded a delivery order valued at $8.4K to AmerisourceBergen Drug Corp for ProQuad vials, with performance in Conshohocken, Pennsylvania and an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price delivery order represents a single medical supply transaction within AmerisourceBergen's broader pharmaceutical distribution portfolio supporting federal healthcare procurement. As a major pharmaceutical distributor headquartered in...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $16,543.30 delivery order to AmerisourceBergen Drug Corp on June 30, 2025, for ProQuad vials with a completion date of July 22, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. The delivery order will be performed at the...
- The Defense Logistics Agency awarded a $1,687.48 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for ProQuad vials with a completion date of August 29, 2025. This firm fixed-price, non-set-aside contract is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a child order under a larger contract vehicle, this delivery order leverages AmerisourceBergen's established relationships with DLA for pharmaceutical supply to...
- The Defense Logistics Agency's Medical Supply Chain awarded a $16.5K firm fixed-price delivery order to AmerisourceBergen Drug Corp for PROQUAD vials, with an ultimate completion date of October 14, 2025. This competitive award, issued on September 22, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order operates under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion...
- The Defense Logistics Agency (DLA) awarded a $1,687.48 firm fixed price delivery order to AmerisourceBergen Drug Corp for ProQuad vials on August 19, 2025, with a completion date of September 10, 2025. This non-set-aside competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The place of performance is located in...
- The Defense Logistics Agency awarded a delivery order valued at $1,687.48 to AmerisourceBergen Drug Corp for ProQuad vials, with a completion date of September 9, 2025. This firm fixed price delivery order, issued on August 18, 2025, represents a pediatric vaccination product delivery to support federal medical supply requirements. The contract was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of ProQuad vials, valued at $8,354.50 with a completion date of September 23, 2025. This is a firm fixed-price delivery order with no set-aside designation, executed under competitive procedures. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a $9,274.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ProQuad vials with an ultimate completion date of October 10, 2025. This is a non-set-aside competitive award issued as a child contract under AmerisourceBergen's larger indefinite delivery vehicle. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order represents a discrete fulfillment under AmerisourceBergen's...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB25FQ2XVDelivery Order
The Defense Logistics Agency awarded a $9,925.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for PROQUAD vials with an ultimate completion date of October 16, 2025. This non-set-aside contract, awarded on September 24, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle running through December 2026. The delivery order will be fulfilled at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is part of AmerisourceBergen's comprehensive role as a prime pharmaceutical vendor supporting the Defense Health Agency and broader military healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen provides a wide range of medical products including vaccines, specialty medications, and medical supplies through competitive federal procurement. The underlying IDC vehicle enables the company to supply critical pharmaceutical commodities globally to support military healthcare programs, with the DLA planning to expand its pharmaceutical prime vendor programs across multiple regions in the coming years.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.9k | 9/24/25 |